iBio Grants Caliber License for Production of Antibodies Targeting Ebola
November 10, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Nov 10, 2014) - iBio, Inc. (NYSE MKT: IBIO) and Caliber Biotherapeutics LLC executed an agreement, effective today, for an emergency use license to the iBioLaunch™...
iBio Expands Exclusive Product Collaboration With Novici Biotech
October 22, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Oct 22, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, and Novici Biotech LLC...
iBio Responds to Inquiries About its Role in Emergency Response to Ebola Virus Disease Outbreak
October 16, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Oct 16, 2014) - iBio, Inc. (NYSE MKT: IBIO) today confirmed, in response to shareholder and media inquiries: (i) the applicability of its issued U.S. iBioLaunch™...
iBio Reports on Filing of 2014 Annual Report
October 03, 2014 17:00 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Oct 3, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced, as required...
Dr. Thomas A. Medsger Jr. Joins iBio Clinical Advisory Board
September 02, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Sep 2, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of biotechnology for developing and manufacturing plant-made pharmaceutical products, has appointed Thomas...
iBio Receives European Patent Allowances for Protein Expression Technology
August 28, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Aug 28, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, received notices of intention to...
iBio Enters Into $10 Million Common Stock Purchase Agreement With Aspire Capital
August 26, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Aug 26, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, today announced it has...
iBio Forms Marketing Collaboration With Kanematsu Chemicals Corporation to Target Japanese Market
August 14, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Aug 14, 2014) - iBio, Inc. (NYSE MKT: IBIO), and Kanematsu Chemicals Corporation, part of Kanematsu Corporation (TSE: 8020), have entered into a collaboration agreement...
iBio Appoints Another IPF Expert, Dr. J. Terrill Huggins, to Clinical Advisory Board
July 30, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Jul 30, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, has appointed J....
iBio Appoints Dr. Richard M. Silver to Clinical Advisory Board
July 21, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Jul 21, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, has appointed Richard...